BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37314622)

  • 1. Acute monocytic leukemia with KMT2A::LASP1 developed 9 months after diagnosis of acute megakaryoblastic leukemia in a 2-year-old boy.
    Fujita T; Fukushima H; Nanmoku T; Arakawa Y; Deguchi T; Suzuki R; Yamaki Y; Hosaka S; Takada H
    Int J Hematol; 2023 Oct; 118(4):514-518. PubMed ID: 37314622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of
    Forlenza CJ; Zhang Y; Yao J; Benayed R; Steinherz P; Ramaswamy K; Kessel R; Roshal M; Shukla N
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30455225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2 Fusion Gene.
    Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review.
    Gao L; Lu J; Li J; Hu Y; Lu Y; Du W; Hu S
    Int J Hematol; 2023 May; 117(5):781-785. PubMed ID: 36472792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
    Lalonde E; Rentas S; Wertheim G; Cao K; Surrey LF; Lin F; Zhao X; Obstfeld A; Aplenc R; Luo M; Li MM
    Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33832921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
    Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
    Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience.
    Athale UH; Razzouk BI; Raimondi SC; Tong X; Behm FG; Head DR; Srivastava DK; Rubnitz JE; Bowman L; Pui CH; Ribeiro RC
    Blood; 2001 Jun; 97(12):3727-32. PubMed ID: 11389009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Prognosis of 27 Patients with Childhood Acute Megakaryoblastic Leukemia.
    Qi H; Mao Y; Cao Q; Sun X; Kuai W; Song J; Ma L; Hong Z; Hu J; Zhou G
    Med Sci Monit; 2020 Jun; 26():e922662. PubMed ID: 32532951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood acute megakaryoblastic leukemia with internalization of hemic cells.
    Shimizu H; Ui T; Sasaki K; Kawai S; Kaneko Y; Fujimoto T
    Am J Pediatr Hematol Oncol; 1990; 12(4):477-9. PubMed ID: 2285130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
    Miyamura T; Kudo K; Tabuchi K; Ishida H; Tomizawa D; Adachi S; Goto H; Yoshida N; Inoue M; Koh K; Sasahara Y; Fujita N; Kakuda H; Noguchi M; Hiwatari M; Hashii Y; Kato K; Atsuta Y; Okamoto Y
    Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene.
    Ishibashi M; Yokosuka T; Yanagimachi MD; Iwasaki F; Tsujimoto SI; Sasaki K; Takeuchi M; Tanoshima R; Kato H; Kajiwara R; Tanaka F; Goto H; Yokota S
    Turk J Haematol; 2016 Dec; 33(4):331-334. PubMed ID: 27094503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
    Schweitzer J; Zimmermann M; Rasche M; von Neuhoff C; Creutzig U; Dworzak M; Reinhardt D; Klusmann JH
    Ann Hematol; 2015 Aug; 94(8):1327-36. PubMed ID: 25913479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and Prognostic Features in Pediatric Acute Megakaryoblastic Leukemia Without Down Syndrome: A Retrospective Study in China.
    Wang Y; Lu A; Jia Y; Zuo Y; Zhang L
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e301-e308. PubMed ID: 33257285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children.
    Lion T; Haas OA; Harbott J; Bannier E; Ritterbach J; Jankovic M; Fink FM; Stojimirovic A; Herrmann J; Riehm HJ
    Blood; 1992 Jun; 79(12):3325-30. PubMed ID: 1596573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL-MLLT10 fusion gene in pediatric acute megakaryoblastic leukemia.
    Morerio C; Rapella A; Tassano E; Rosanda C; Panarello C
    Leuk Res; 2005 Oct; 29(10):1223-6. PubMed ID: 16111539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
    Wang Z; Shi Y; Liu H; Liang Z; Zhu Q; Wang L; Tang B; Miao S; Ma N; Cen X; Ren H; Dong Y
    Hematol Oncol; 2019 Dec; 37(5):617-625. PubMed ID: 31701557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of Clinical Characteristics and Prognosis in Children with Acute Megakaryoblastic Leukemia without Down Syndrome].
    Lin SF; Guo SY; Liu S; Wang J; Huang K; Li Y; Fang JP; Zhou DH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):374-380. PubMed ID: 33812402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children.
    Masetti R; Guidi V; Ronchini L; Bertuccio NS; Locatelli F; Pession A
    Crit Rev Oncol Hematol; 2019 Jun; 138():132-138. PubMed ID: 31092368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial.
    Teyssier AC; Lapillonne H; Pasquet M; Ballerini P; Baruchel A; Ducassou S; Fenneteau O; Petit A; Cuccuini W; Ragu C; Preudhomme C; Mercher T; Sirvent N; Leverger G
    Pediatr Hematol Oncol; 2017 Nov; 34(8):425-427. PubMed ID: 29303660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.